Harvard Bioscience (HBIO) 6.06 $HBIO
Harvard Bioscience Schedules First Quarter 2015 Conference Call for April 30 at 11:00 AM ET
GlobeNewswire - Tue Apr 21, 3:05PM CDT
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its first quarter 2015 before market trading hours on Thursday, April 30, 2015. A conference call to discuss the company's first quarter 2015 financial results and its operations is scheduled for that same date at 11:00 AM ET. On that call, management may respond to questions from the audience and provide information on any of a number of topics related to the business, including operations, plans and outlook.
HBIO: 6.06 (-0.29)
Harvard Bioscience Shares Up 40.9% Since SmarTrend's Buy Recommendation (HBIO)
Comtex SmarTrend(R) - Thu Apr 16, 4:50PM CDT
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 6 months, Harvard Bioscience has returned 40.94% as of today's recent price of $6.61.
HBIO: 6.06 (-0.29)
The Best Small Cap Stocks To Buy Now
Todd Campbell - at Seeking Alpha - Mon Apr 06, 4:40AM CDT
PMC: 28.80 (+0.80), MATW: 50.74 (+0.08), ELLI: 57.00 (-0.45), SILC: 41.72 (+0.45), SGMO: 14.37 (-0.03), AFFX: 12.57 (-0.13), BABY: 41.64 (+1.71), HBIO: 6.06 (-0.29), EXAM: 42.52 (-0.16), IART: 59.75 (-0.26), SNCR: 51.87 (+0.02), CNMD: 49.35 (+0.36), BJRI: 50.54 (-1.00), NLNK: 53.12 (-0.07), CTRN: 24.27 (+0.16), ANAC: 66.45 (-0.22), PRSC: 49.43 (+0.42), RRGB: 80.99 (-2.02), ALOG: 87.92 (+0.38), DIOD: 28.02 (+0.12), LGND: 87.71 (-0.58), DEPO: 27.14 (+0.65), ASTE: 42.80 (+0.16), DYAX: 28.12 (+0.15), FARO: 44.64 (-0.93), ECOL: 48.69 (+0.16), PFPT: 58.45 (-0.45), MTSI: 34.46 (-0.27), IRWD: 15.07 (-0.19), ABAX: 63.25 (-0.09), ANIP: 69.79 (+1.24), FORM: 9.44 (+0.05), QLGC: 15.08 (+0.44), ADUS: 27.60 (-0.33), SNHY: 40.71 (+0.16), EBIX: 29.77 (+0.86), SWHC: 14.68 (-0.12)
Harvard Bioscience Up 24.5% Since SmarTrend Uptrend Call (HBIO)
Comtex SmarTrend(R) - Thu Apr 02, 10:02AM CDT
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 5 months, Harvard Bioscience has returned 24.52% as of today's recent price of $5.84.
HBIO: 6.06 (-0.29)
Uptrend Call Working As Harvard Bioscience Stock Rises 15.8% (HBIO)
Comtex SmarTrend(R) - Wed Mar 25, 5:10PM CDT
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 5 months, Harvard Bioscience has returned 15.78% as of today's recent price of $5.43.
HBIO: 6.06 (-0.29)
Leading 100 Medical Devices Companies of USA/Canada 2015
M2 - Mon Mar 23, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9k2tjj/usacanada) has announced the addition of the "USA/Canada Medical Devices 100: An Industry Report" report to their offering. The United States is the largest medical device market in the world with a market size of around $110 billion, and it is expected to reach $133 billion by 2016 The U.S. market value represented about 38 percent of the global medical device market in 2012. The U.S. medical device companies are highly regarded globally for their innovations and high technology products. Canada's medical device market ranks as the ninth largest in the world. Canada has an estimated around $7 billion medical device market accounting for about 2 percent of the global market. The market is projected to increase at a CAGR of 4.0% to reach US$8.3bn by 2018. Around 80% of the market is supplied by imports, principally from the USA. With this special industry report, our endeavor is to provide the new investors with a complete resourceful research report for familiarizing with the present investment trends in USA/Canadian medical devices industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices companies of USA/Canada - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances with foreign companies - International presence of USA/Canadian medical devices companies - R&D activities in the industry Report Includes Companies Engaged in: - Manufacturing medical equipments/devices that have life span of more than one year and that can be used repeatedly on multiple patients or multiple medical tests can be done by using them - Manufacturing medical devices providing any medical activity and/or treatment - Manufacturing diagnostic devices - Manufacturing high-tech medical instruments - Manufacturing life-support medical devices Key Features: - Financial information compiled from reliable primary and secondary sources - Business news and transactions compiled from primary news sources, company websites, and press releases - Original news source links provided for each news for further reference - Senior colleagues who analyze news have years of experience Companies Mentioned (Partial List) - Harvard Bioscience, Inc. (United States) - Hasco Medical, Incorporation (United States) - Heartware International Inc (United States) - HEI Inc (United States) - Hill-Rom Holdings, Incorporation (United States) - Hologic, Inc. (United States) - IDEXX Laboratories Inc (United States) - Illumina, Inc. (United States) - Imris Incorporation (Canada) - Inogen Inc (United States) - Insulet Corporation (United States) - Integra LifeSciences Holdings Corporation (United States) - Invacare Corporation (United States) - IRIDEX Corporation (United States) - Lifeline Scientific, Inc (United States) - Lifeloc Technologies Inc (United States) - Medifocus Inc (Canada) For more information visit http://www.researchandmarkets.com/research/9k2tjj/usacanada
IRIX: 9.81 (-0.08), ILMN: 190.04 (-9.27), HBIO: 6.06 (-0.29), PODD: 30.79 (-0.20), IART: 59.75 (-0.26), IVC: 19.80 (+0.24), IMRS: 0.74 (unch), INGN: 36.39 (-0.04), IDXX: 155.97 (+0.75), HRC: 52.01 (+0.29), HOLX: 33.26 (-0.07)
The Best Small Cap Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sat Mar 21, 11:24PM CDT
DMND: 30.74 (+0.01), PMC: 28.80 (+0.80), MATW: 50.74 (+0.08), ELLI: 57.00 (-0.45), WWE: 14.19 (+0.04), SILC: 41.72 (+0.45), SGMO: 14.37 (-0.03), TRNX: 25.96 (-0.06), OFIX: 36.22 (-0.21), AFFX: 12.57 (-0.13), CHE: 122.49 (+0.25), BABY: 41.64 (+1.71), HBIO: 6.06 (-0.29), IART: 59.75 (-0.26), SONC: 30.75 (+0.14), SNCR: 51.87 (+0.02), CNMD: 49.35 (+0.36), BJRI: 50.54 (-1.00), NLNK: 53.12 (-0.07), ANAC: 66.45 (-0.22), XSD: 89.10 (+0.13), PRSC: 49.43 (+0.42), RRGB: 80.99 (-2.02), IPAR: 32.16 (+0.16), ALOG: 87.92 (+0.38), DIOD: 28.02 (+0.12), NSIT: 29.01 (+0.22), LGND: 87.71 (-0.58), DEPO: 27.14 (+0.65), ASTE: 42.80 (+0.16), DYAX: 28.12 (+0.15), ECOL: 48.69 (+0.16), PFPT: 58.45 (-0.45), MTSI: 34.46 (-0.27), IRWD: 15.07 (-0.19), ABAX: 63.25 (-0.09), FLDM: 43.04 (-1.36), SCSS: 34.12 (+0.30), ANIP: 69.79 (+1.24), FORM: 9.44 (+0.05), BEAT: 8.82 (-0.13), QLGC: 15.08 (+0.44), ADUS: 27.60 (-0.33), PENX: 18.98 (+0.14), EBIX: 29.77 (+0.86), CORT: 6.44 (+0.38), SWHC: 14.68 (-0.12), OCFC: 16.93 (+0.01)
11.7% Return Seen to Date on SmarTrend Harvard Bioscience Call (HBIO)
Comtex SmarTrend(R) - Wed Mar 18, 11:41AM CDT
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 5 months, Harvard Bioscience has returned 11.73% as of today's recent price of $5.24.
HBIO: 6.06 (-0.29)
Harvard Bioscience' (HBIO) CEO Jeffrey Duchemin on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 26, 2:41PM CST
HBIO: 6.06 (-0.29)
Harvard Bioscience posts 4Q loss
Automated Insights - Thu Feb 26, 10:48AM CST
HOLLISTON, Mass. (AP) _ Harvard Bioscience Inc. (HBIO) on Thursday reported a loss of $19,000 in its fourth quarter.
HBIO: 6.06 (-0.29)
Harvard Bioscience (HBIO) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 26, 9:55AM CST
HBIO: 6.06 (-0.29)
Harvard Bioscience beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 6:33AM CST
HBIO: 6.06 (-0.29)
The Top Small Cap Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sun Feb 22, 2:51AM CST
MATW: 50.74 (+0.08), RTIX: 5.69 (-0.10), ELLI: 57.00 (-0.45), KFRC: 22.02 (-0.13), SILC: 41.72 (+0.45), SGMO: 14.37 (-0.03), AFFX: 12.57 (-0.13), BABY: 41.64 (+1.71), HBIO: 6.06 (-0.29), EXAM: 42.52 (-0.16), IART: 59.75 (-0.26), UEIC: 57.71 (+0.45), CNMD: 49.35 (+0.36), BJRI: 50.54 (-1.00), NLNK: 53.12 (-0.07), CTRN: 24.27 (+0.16), ANAC: 66.45 (-0.22), CSU: 26.62 (+0.09), RRGB: 80.99 (-2.02), DIOD: 28.02 (+0.12), DEPO: 27.14 (+0.65), DYAX: 28.12 (+0.15), FARO: 44.64 (-0.93), PERY: 24.97 (-0.22), PACB: 5.90 (-0.07), PFPT: 58.45 (-0.45), MTSI: 34.46 (-0.27), IRWD: 15.07 (-0.19), ABAX: 63.25 (-0.09), SCSS: 34.12 (+0.30), ANIP: 69.79 (+1.24), FORM: 9.44 (+0.05), BEAT: 8.82 (-0.13), QLGC: 15.08 (+0.44), PENX: 18.98 (+0.14), EBIX: 29.77 (+0.86), CORT: 6.44 (+0.38), UTMD: 56.00 (+0.90), DAVE: 29.37 (+0.05), SWHC: 14.68 (-0.12)
Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 20, 8:00AM CST
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
LXRX: 1.06 (-0.01), AMRN: 2.34 (-0.05), HWAY: 18.99 (-0.08), HLS: 46.35 (+0.48), CYBX: 63.59 (+0.27), ESRX: 86.12 (+0.02), ECYT: 6.37 (unch), DXCM: 69.28 (-1.05), NSTG: 12.25 (-0.02), SRPT: 13.52 (+0.04), HZNP: 30.96 (+0.10), MDXG: 10.21 (-0.17), DEPO: 27.14 (+0.65), ANIK: 38.68 (+0.05), NKTR: 10.90 (+0.16), KERX: 11.52 (-0.15), ALIM: 4.92 (-0.09), EPZM: 19.45 (+0.45), AEGR: 25.65 (+0.06), MDRX: 12.30 (+0.12), ELGX: 17.07 (+0.15), NUVA: 43.38 (+0.10), HPTX: 45.96 (-0.18), GNMK: 10.51 (-0.22), MDVN: 128.88 (+0.29), HBIO: 6.06 (-0.29), ACAD: 38.55 (-0.20), ST: 58.27 (+0.21), RPTP: 10.56 (-0.17), FMI: 48.71 (-0.96), GMED: 25.09 (-0.16), JAZZ: 186.13 (-0.41), PTCT: 70.98 (unch), INFI: 14.71 (-0.28), ARNA: 4.47 (+0.01), EXEL: 3.12 (+0.05), NEO: 4.84 (-0.03), EXAS: 22.28 (+0.24), ALKS: 62.60 (-0.24), HTWR: 77.60 (-2.35), MNKD: 4.90 (-0.09), IPXL: 49.58 (-0.40), SQNM: 4.47 (+0.08), HALO: 16.03 (+0.15), ISIS: 66.26 (-0.03), CLVS: 85.04 (-1.36), BIO: 136.64 (+0.02), BIOS: 5.23 (+0.04), PCRX: 83.61 (-0.41)
Harvard Bioscience Appoints Ryan Atienza to Vice President of Sales at Its Denville Scientific Subsidiary
GlobeNewswire - Wed Feb 18, 6:06AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, has appointed Ryan Atienza to Vice President of Sales, a newly created position, at its Denville Scientific subsidiary, effective February 16. Mr. Atienza will be a member of the executive leadership team responsible for North American sales.
HBIO: 6.06 (-0.29), BDX: 144.33 (-1.24), AXP: 78.44 (+1.16)
Harvard Bioscience Shares Up 13.4% Since SmarTrend's Buy Recommendation (HBIO)
Comtex SmarTrend(R) - Tue Feb 17, 5:13PM CST
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 4 months, Harvard Bioscience has returned 13.43% as of today's recent price of $5.32.
HBIO: 6.06 (-0.29)
Harvard Bioscience Schedules Fourth Quarter and Year-End 2014 Conference Call for February 26 at 11:00 AM ET
GlobeNewswire - Fri Feb 13, 6:00AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, will announce results for its fourth quarter and year-end 2014 before market trading hours on Thursday, February 26, 2015. A conference call to discuss the company's fourth quarter and year-end 2014 and its operations is scheduled for that same date at 11:00 AM ET. On that call, management may respond to questions from the audience and provide information on any of a number of topics related to the business, including operations, plans and outlook.
HBIO: 6.06 (-0.29)
Harvard Bioscience Up 11.6% Since SmarTrend Uptrend Call (HBIO)
Comtex SmarTrend(R) - Tue Feb 10, 9:22AM CST
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 4 months, Harvard Bioscience has returned 11.62% as of today's recent price of $5.24.
HBIO: 6.06 (-0.29)
Harvard Bioscience Schedules First Quarter 2015 Conference Call for April 30 at 11:00 AM ET
GlobeNewswire - Tue Apr 21, 3:05PM CDT
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its first quarter 2015 before market trading hours on Thursday, April 30, 2015. A conference call to discuss the company's first quarter 2015 financial results and its operations is scheduled for that same date at 11:00 AM ET. On that call, management may respond to questions from the audience and provide information on any of a number of topics related to the business, including operations, plans and outlook.
HBIO: 6.06 (-0.29)
Harvard Bioscience Shares Up 40.9% Since SmarTrend's Buy Recommendation (HBIO)
Comtex SmarTrend(R) - Thu Apr 16, 4:50PM CDT
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 6 months, Harvard Bioscience has returned 40.94% as of today's recent price of $6.61.
HBIO: 6.06 (-0.29)
The Best Small Cap Stocks To Buy Now
Todd Campbell - at Seeking Alpha - Mon Apr 06, 4:40AM CDT
PMC: 28.80 (+0.80), MATW: 50.74 (+0.08), ELLI: 57.00 (-0.45), SILC: 41.72 (+0.45), SGMO: 14.37 (-0.03), AFFX: 12.57 (-0.13), BABY: 41.64 (+1.71), HBIO: 6.06 (-0.29), EXAM: 42.52 (-0.16), IART: 59.75 (-0.26), SNCR: 51.87 (+0.02), CNMD: 49.35 (+0.36), BJRI: 50.54 (-1.00), NLNK: 53.12 (-0.07), CTRN: 24.27 (+0.16), ANAC: 66.45 (-0.22), PRSC: 49.43 (+0.42), RRGB: 80.99 (-2.02), ALOG: 87.92 (+0.38), DIOD: 28.02 (+0.12), LGND: 87.71 (-0.58), DEPO: 27.14 (+0.65), ASTE: 42.80 (+0.16), DYAX: 28.12 (+0.15), FARO: 44.64 (-0.93), ECOL: 48.69 (+0.16), PFPT: 58.45 (-0.45), MTSI: 34.46 (-0.27), IRWD: 15.07 (-0.19), ABAX: 63.25 (-0.09), ANIP: 69.79 (+1.24), FORM: 9.44 (+0.05), QLGC: 15.08 (+0.44), ADUS: 27.60 (-0.33), SNHY: 40.71 (+0.16), EBIX: 29.77 (+0.86), SWHC: 14.68 (-0.12)
Harvard Bioscience Up 24.5% Since SmarTrend Uptrend Call (HBIO)
Comtex SmarTrend(R) - Thu Apr 02, 10:02AM CDT
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 5 months, Harvard Bioscience has returned 24.52% as of today's recent price of $5.84.
HBIO: 6.06 (-0.29)
Uptrend Call Working As Harvard Bioscience Stock Rises 15.8% (HBIO)
Comtex SmarTrend(R) - Wed Mar 25, 5:10PM CDT
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 5 months, Harvard Bioscience has returned 15.78% as of today's recent price of $5.43.
HBIO: 6.06 (-0.29)
Leading 100 Medical Devices Companies of USA/Canada 2015
M2 - Mon Mar 23, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9k2tjj/usacanada) has announced the addition of the "USA/Canada Medical Devices 100: An Industry Report" report to their offering. The United States is the largest medical device market in the world with a market size of around $110 billion, and it is expected to reach $133 billion by 2016 The U.S. market value represented about 38 percent of the global medical device market in 2012. The U.S. medical device companies are highly regarded globally for their innovations and high technology products. Canada's medical device market ranks as the ninth largest in the world. Canada has an estimated around $7 billion medical device market accounting for about 2 percent of the global market. The market is projected to increase at a CAGR of 4.0% to reach US$8.3bn by 2018. Around 80% of the market is supplied by imports, principally from the USA. With this special industry report, our endeavor is to provide the new investors with a complete resourceful research report for familiarizing with the present investment trends in USA/Canadian medical devices industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices companies of USA/Canada - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances with foreign companies - International presence of USA/Canadian medical devices companies - R&D activities in the industry Report Includes Companies Engaged in: - Manufacturing medical equipments/devices that have life span of more than one year and that can be used repeatedly on multiple patients or multiple medical tests can be done by using them - Manufacturing medical devices providing any medical activity and/or treatment - Manufacturing diagnostic devices - Manufacturing high-tech medical instruments - Manufacturing life-support medical devices Key Features: - Financial information compiled from reliable primary and secondary sources - Business news and transactions compiled from primary news sources, company websites, and press releases - Original news source links provided for each news for further reference - Senior colleagues who analyze news have years of experience Companies Mentioned (Partial List) - Harvard Bioscience, Inc. (United States) - Hasco Medical, Incorporation (United States) - Heartware International Inc (United States) - HEI Inc (United States) - Hill-Rom Holdings, Incorporation (United States) - Hologic, Inc. (United States) - IDEXX Laboratories Inc (United States) - Illumina, Inc. (United States) - Imris Incorporation (Canada) - Inogen Inc (United States) - Insulet Corporation (United States) - Integra LifeSciences Holdings Corporation (United States) - Invacare Corporation (United States) - IRIDEX Corporation (United States) - Lifeline Scientific, Inc (United States) - Lifeloc Technologies Inc (United States) - Medifocus Inc (Canada) For more information visit http://www.researchandmarkets.com/research/9k2tjj/usacanada
IRIX: 9.81 (-0.08), ILMN: 190.04 (-9.27), HBIO: 6.06 (-0.29), PODD: 30.79 (-0.20), IART: 59.75 (-0.26), IVC: 19.80 (+0.24), IMRS: 0.74 (unch), INGN: 36.39 (-0.04), IDXX: 155.97 (+0.75), HRC: 52.01 (+0.29), HOLX: 33.26 (-0.07)
The Best Small Cap Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sat Mar 21, 11:24PM CDT
DMND: 30.74 (+0.01), PMC: 28.80 (+0.80), MATW: 50.74 (+0.08), ELLI: 57.00 (-0.45), WWE: 14.19 (+0.04), SILC: 41.72 (+0.45), SGMO: 14.37 (-0.03), TRNX: 25.96 (-0.06), OFIX: 36.22 (-0.21), AFFX: 12.57 (-0.13), CHE: 122.49 (+0.25), BABY: 41.64 (+1.71), HBIO: 6.06 (-0.29), IART: 59.75 (-0.26), SONC: 30.75 (+0.14), SNCR: 51.87 (+0.02), CNMD: 49.35 (+0.36), BJRI: 50.54 (-1.00), NLNK: 53.12 (-0.07), ANAC: 66.45 (-0.22), XSD: 89.10 (+0.13), PRSC: 49.43 (+0.42), RRGB: 80.99 (-2.02), IPAR: 32.16 (+0.16), ALOG: 87.92 (+0.38), DIOD: 28.02 (+0.12), NSIT: 29.01 (+0.22), LGND: 87.71 (-0.58), DEPO: 27.14 (+0.65), ASTE: 42.80 (+0.16), DYAX: 28.12 (+0.15), ECOL: 48.69 (+0.16), PFPT: 58.45 (-0.45), MTSI: 34.46 (-0.27), IRWD: 15.07 (-0.19), ABAX: 63.25 (-0.09), FLDM: 43.04 (-1.36), SCSS: 34.12 (+0.30), ANIP: 69.79 (+1.24), FORM: 9.44 (+0.05), BEAT: 8.82 (-0.13), QLGC: 15.08 (+0.44), ADUS: 27.60 (-0.33), PENX: 18.98 (+0.14), EBIX: 29.77 (+0.86), CORT: 6.44 (+0.38), SWHC: 14.68 (-0.12), OCFC: 16.93 (+0.01)
11.7% Return Seen to Date on SmarTrend Harvard Bioscience Call (HBIO)
Comtex SmarTrend(R) - Wed Mar 18, 11:41AM CDT
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 5 months, Harvard Bioscience has returned 11.73% as of today's recent price of $5.24.
HBIO: 6.06 (-0.29)
Harvard Bioscience' (HBIO) CEO Jeffrey Duchemin on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 26, 2:41PM CST
HBIO: 6.06 (-0.29)
Harvard Bioscience posts 4Q loss
Automated Insights - Thu Feb 26, 10:48AM CST
HOLLISTON, Mass. (AP) _ Harvard Bioscience Inc. (HBIO) on Thursday reported a loss of $19,000 in its fourth quarter.
HBIO: 6.06 (-0.29)
Harvard Bioscience (HBIO) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 26, 9:55AM CST
HBIO: 6.06 (-0.29)
Harvard Bioscience beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 6:33AM CST
HBIO: 6.06 (-0.29)
The Top Small Cap Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sun Feb 22, 2:51AM CST
MATW: 50.74 (+0.08), RTIX: 5.69 (-0.10), ELLI: 57.00 (-0.45), KFRC: 22.02 (-0.13), SILC: 41.72 (+0.45), SGMO: 14.37 (-0.03), AFFX: 12.57 (-0.13), BABY: 41.64 (+1.71), HBIO: 6.06 (-0.29), EXAM: 42.52 (-0.16), IART: 59.75 (-0.26), UEIC: 57.71 (+0.45), CNMD: 49.35 (+0.36), BJRI: 50.54 (-1.00), NLNK: 53.12 (-0.07), CTRN: 24.27 (+0.16), ANAC: 66.45 (-0.22), CSU: 26.62 (+0.09), RRGB: 80.99 (-2.02), DIOD: 28.02 (+0.12), DEPO: 27.14 (+0.65), DYAX: 28.12 (+0.15), FARO: 44.64 (-0.93), PERY: 24.97 (-0.22), PACB: 5.90 (-0.07), PFPT: 58.45 (-0.45), MTSI: 34.46 (-0.27), IRWD: 15.07 (-0.19), ABAX: 63.25 (-0.09), SCSS: 34.12 (+0.30), ANIP: 69.79 (+1.24), FORM: 9.44 (+0.05), BEAT: 8.82 (-0.13), QLGC: 15.08 (+0.44), PENX: 18.98 (+0.14), EBIX: 29.77 (+0.86), CORT: 6.44 (+0.38), UTMD: 56.00 (+0.90), DAVE: 29.37 (+0.05), SWHC: 14.68 (-0.12)
Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 20, 8:00AM CST
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
LXRX: 1.06 (-0.01), AMRN: 2.34 (-0.05), HWAY: 18.99 (-0.08), HLS: 46.35 (+0.48), CYBX: 63.59 (+0.27), ESRX: 86.12 (+0.02), ECYT: 6.37 (unch), DXCM: 69.28 (-1.05), NSTG: 12.25 (-0.02), SRPT: 13.52 (+0.04), HZNP: 30.96 (+0.10), MDXG: 10.21 (-0.17), DEPO: 27.14 (+0.65), ANIK: 38.68 (+0.05), NKTR: 10.90 (+0.16), KERX: 11.52 (-0.15), ALIM: 4.92 (-0.09), EPZM: 19.45 (+0.45), AEGR: 25.65 (+0.06), MDRX: 12.30 (+0.12), ELGX: 17.07 (+0.15), NUVA: 43.38 (+0.10), HPTX: 45.96 (-0.18), GNMK: 10.51 (-0.22), MDVN: 128.88 (+0.29), HBIO: 6.06 (-0.29), ACAD: 38.55 (-0.20), ST: 58.27 (+0.21), RPTP: 10.56 (-0.17), FMI: 48.71 (-0.96), GMED: 25.09 (-0.16), JAZZ: 186.13 (-0.41), PTCT: 70.98 (unch), INFI: 14.71 (-0.28), ARNA: 4.47 (+0.01), EXEL: 3.12 (+0.05), NEO: 4.84 (-0.03), EXAS: 22.28 (+0.24), ALKS: 62.60 (-0.24), HTWR: 77.60 (-2.35), MNKD: 4.90 (-0.09), IPXL: 49.58 (-0.40), SQNM: 4.47 (+0.08), HALO: 16.03 (+0.15), ISIS: 66.26 (-0.03), CLVS: 85.04 (-1.36), BIO: 136.64 (+0.02), BIOS: 5.23 (+0.04), PCRX: 83.61 (-0.41)
Harvard Bioscience Appoints Ryan Atienza to Vice President of Sales at Its Denville Scientific Subsidiary
GlobeNewswire - Wed Feb 18, 6:06AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, has appointed Ryan Atienza to Vice President of Sales, a newly created position, at its Denville Scientific subsidiary, effective February 16. Mr. Atienza will be a member of the executive leadership team responsible for North American sales.
HBIO: 6.06 (-0.29), BDX: 144.33 (-1.24), AXP: 78.44 (+1.16)
Harvard Bioscience Shares Up 13.4% Since SmarTrend's Buy Recommendation (HBIO)
Comtex SmarTrend(R) - Tue Feb 17, 5:13PM CST
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 4 months, Harvard Bioscience has returned 13.43% as of today's recent price of $5.32.
HBIO: 6.06 (-0.29)
Harvard Bioscience Schedules Fourth Quarter and Year-End 2014 Conference Call for February 26 at 11:00 AM ET
GlobeNewswire - Fri Feb 13, 6:00AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, will announce results for its fourth quarter and year-end 2014 before market trading hours on Thursday, February 26, 2015. A conference call to discuss the company's fourth quarter and year-end 2014 and its operations is scheduled for that same date at 11:00 AM ET. On that call, management may respond to questions from the audience and provide information on any of a number of topics related to the business, including operations, plans and outlook.
HBIO: 6.06 (-0.29)
Harvard Bioscience Up 11.6% Since SmarTrend Uptrend Call (HBIO)
Comtex SmarTrend(R) - Tue Feb 10, 9:22AM CST
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 4 months, Harvard Bioscience has returned 11.62% as of today's recent price of $5.24.
HBIO: 6.06 (-0.29)
